Vaayath Consulting Services Regulatory Update · CDSCO / Gazette Notification Drugs (Eighth Amendment) Rules, 2026: CLAA Licensing Framework Now Explicitly Covers Cell & Stem Cell Products, Gene Therapeutics and Xenografts G.S.R. 530(E) brings advanced therapy products formally within the same…
Recent Post
- D&C Amended to Cover Licensing of Stem Cell Products, Gene Therapeutics and Xenografts
- Schedule H2 Expanded: Antimicrobials and Many Other Drugs Now Under Stricter Controls
- CDSCO Restricts IVF Supplies to Registered ART Centres
- CDSCO Issues Clarity on New Drugs, DC Granules & MR Pellets Licensing
- Centre Bans 16 Fixed Dose Combinations Under Section 26A of Drugs & Cosmetics Act
